We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMHI icon
1051
SEACOR Marine Holdings
SMHI
$262M
$39.1M ﹤0.01%
4,840,112
+706,846
+17% +$3.45M
ALLO icon
1052
Allogene Therapeutics
ALLO
$683M
$38.9M ﹤0.01%
4,266,735
+1,015,207
+31% +$10.6M
REAL icon
1053
The RealReal
REAL
$1.33B
$38.8M ﹤0.01%
5,347,314
+2,011,835
+60% +$17.8M
PATK icon
1054
Patrick Industries
PATK
$2.78B
$38.8M ﹤0.01%
965,061
-245,049
-20% -$11.3M
NDAQ icon
1055
Nasdaq
NDAQ
$54.6B
$38.7M ﹤0.01%
651,867
-38,037
-6% -$2.25M
MOS icon
1056
The Mosaic Company
MOS
$6.92B
$38.4M ﹤0.01%
577,842
+34,538
+6% +$1.73M
KAHC.U
1057
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$38.4M ﹤0.01%
3,861,073
EIX icon
1058
Edison International
EIX
$27.2B
$38.3M ﹤0.01%
545,712
-23,466
-4% -$1.5M
LYB icon
1059
LyondellBasell Industries
LYB
$20.2B
$38.2M ﹤0.01%
371,655
-18,532
-5% -$1.85M
INSW icon
1060
International Seaways
INSW
$4.71B
$38.2M ﹤0.01%
2,114,794
-11,855
-0.6% -$192K
LECO icon
1061
Lincoln Electric
LECO
$15.5B
$37.7M ﹤0.01%
273,332
+3,977
+1% +$521K
AEPPZ
1062
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
$37.5M ﹤0.01%
664,885
-20,893
-3% -$1.11M
BLFY
1063
DELISTED
Blue Foundry Bancorp
BLFY
$37.2M ﹤0.01%
2,746,634
+416,424
+18% +$5.88M
APPS icon
1064
Digital Turbine
APPS
$1.53B
$37.1M ﹤0.01%
847,567
-25,776
-3% -$1.16M
TTGT icon
1065
TechTarget
TTGT
$277M
$37M ﹤0.01%
455,819
+2,003
+0.4% +$161K
QTRX icon
1066
Quanterix
QTRX
$135M
$37M ﹤0.01%
1,267,338
-178,264
-12% -$5.45M
HEPS
1067
D-Market Electronic Services & Trading
HEPS
$1.01B
$36.7M ﹤0.01%
16,159,295
-2,821,777
-15% -$5.47M
IIPR icon
1068
Innovative Industrial Properties
IIPR
$1.67B
$36.3M ﹤0.01%
176,618
-8,353
-5% -$1.64M
ADCT icon
1069
ADC Therapeutics
ADCT
$134M
$36.2M ﹤0.01%
2,462,636
-388,801
-14% -$6.17M
EXPD icon
1070
Expeditors International
EXPD
$24.3B
$36M ﹤0.01%
348,918
-11,050
-3% -$1.22M
FLS icon
1071
Flowserve
FLS
$10.3B
$36M ﹤0.01%
1,001,432
-1,210,575
-55% -$39.6M
CLDX icon
1072
Celldex Therapeutics
CLDX
$3.35B
$35.9M ﹤0.01%
1,054,325
+138,717
+15% +$4.43M
TNYA icon
1073
Tenaya Therapeutics
TNYA
$164M
$35.7M ﹤0.01%
3,031,402
+37,899
+1% +$459K
BLBD icon
1074
Blue Bird Corp
BLBD
$2.05B
$35.6M ﹤0.01%
1,891,088
-49,029
-3% -$893K
DNA icon
1075
Ginkgo Bioworks
DNA
$488M
$35.6M ﹤0.01%
220,779
+164,045
+289% +$31.9M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.